SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-093029
Filing Date
2021-07-16
Accepted
2021-07-16 15:21:34
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tmb-20210331x10q.htm   iXBRL 10-Q 703261
2 EXHIBIT 31.1 tmb-20210331xex31d1.htm EX-31.1 12527
3 EXHIBIT 31.2 tmb-20210331xex31d2.htm EX-31.2 11747
4 EXHIBIT 32.1 tmb-20210331xex32d1.htm EX-32.1 5875
5 EXHIBIT 32.2 tmb-20210331xex32d2.htm EX-32.2 5915
  Complete submission text file 0001104659-21-093029.txt   3911774

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210331.xsd EX-101.SCH 47892
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmb-20210331_cal.xml EX-101.CAL 29066
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210331_def.xml EX-101.DEF 169483
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210331_lab.xml EX-101.LAB 328359
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210331_pre.xml EX-101.PRE 269942
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210331x10q_htm.xml XML 527629
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Filer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40119 | Film No.: 211095359
SIC: 6770 Blank Checks